banner

Who we are

The Board

MD, Professor of Medicine, Head of Traslational Liver Research, IRCCS, Humanitas, Milan, Italy
Associate Research Professor at the Barcelona Institute of Global Health (ISGlobal), Hospital Clínic; Associate Professor at the University of Barcelona
Director of the Clinic of Gastroenterology at the University Hospital, Leipzig, Germany and Vice-Secretary EASL
MD Ph.D, Professor in the Division of Infectious Disease Department of Internal Medicine USF Health Morsani College of Medicine, President of the Global Virus Network
Professor of Medicine at the University of Barcelona and Director of the Barcelona Clinic Liver Cancer (BCLC) Group at the Hospital Clinic of Barcelona, Spain
Professor of Paediatrics at Ain Shams University, Cairo, Egypt, Vice Chair of the WHO’s Technical Advisory Group for Prevention and Control of Hepatitis in Egypt and supervisor of the Egyptian national program for control of viral hepatitis at the Ministry of Health
Professor at the Department of Medicine and Department of Pathology and Immunology at the University Hospitals of Geneva, Switzerland
Professor of Experimental Hepatology and Director of the Centre for Liver Research, University of Birmingham, Consultant Hepatologist at the Liver Unit, Queen Elizabeth Hospital, Birmingham and Secretary General EASL
Professor of Banking and Finance and Vice President at Bocconi University in Milan, Chairman of Borsa Italiana SpA and member of the Board of Directors London Stock Exchange Group
Professor of Hepatology at Imperial College, Head of the Digestive Diseases Division and lead clinician for hepatology at St Mary’s Hospital, London, UK

Secretariat

Maguy Sicuro
Director
Marijana Dudek
Executive Assistant
Henry Mark
Programme Manager

The Board

MD, Professor of Medicine, Head of Traslational Liver Research, IRCCS, Humanitas, Milan, Italy
Associate Research Professor at the Barcelona Institute of Global Health (ISGlobal), Hospital Clínic; Associate Professor at the University of Barcelona
Director of the Clinic of Gastroenterology at the University Hospital, Leipzig, Germany and Vice-Secretary EASL
MD Ph.D, Professor in the Division of Infectious Disease Department of Internal Medicine USF Health Morsani College of Medicine, President of the Global Virus Network
Professor of Medicine at the University of Barcelona and Director of the Barcelona Clinic Liver Cancer (BCLC) Group at the Hospital Clinic of Barcelona, Spain
Professor of Paediatrics at Ain Shams University, Cairo, Egypt, Vice Chair of the WHO’s Technical Advisory Group for Prevention and Control of Hepatitis in Egypt and supervisor of the Egyptian national program for control of viral hepatitis at the Ministry of Health
Professor at the Department of Medicine and Department of Pathology and Immunology at the University Hospitals of Geneva, Switzerland
Professor of Experimental Hepatology and Director of the Centre for Liver Research, University of Birmingham, Consultant Hepatologist at the Liver Unit, Queen Elizabeth Hospital, Birmingham and Secretary General EASL
Professor of Banking and Finance and Vice President at Bocconi University in Milan, Chairman of Borsa Italiana SpA and member of the Board of Directors London Stock Exchange Group
Professor of Hepatology at Imperial College, Head of the Digestive Diseases Division and lead clinician for hepatology at St Mary’s Hospital, London, UK

Secretariat

Maguy Sicuro
Director
Marijana Dudek
Executive Assistant
Henry Mark
Programme Manager